BRCA1 and breast cancer: Our data would suggest that, for women who had a breast cancer where the histology is of a TNT or grade 3 ER-positive HER2-negative phenotype in association with a high MS, there may be merit it considering testing for germline PALB2_PGVs where BRCA1/2 testing was negative.